Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $71.7 million versus the consensus estimate of $59.33 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.